Tirado Kulieva, Vicente AmirpashaHernández Martínez, ErnestoChoque Rivera, Tania Jakeline2026-03-042026-03-042022-09-19Tirado-Kulieva, V.A., Hernández-Martínez, E., & Choque-Rivera, T.J. (2022). Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19. Heliyon, 8(9), e10702. https://doi.org/10.1016/j.heliyon.2022.e1070210.1016/J.HELIYON.2022.E10702https://hdl.handle.net/20.500.14845/439Phenolic compounds are essential due to their antioxidant activity and high antiviral potential. In this context, this review reports the main findings on the effect of phenolic compounds (PCs) against SARS-CoV-2 virus. First, the proven activity of PCs against different human viruses is briefly detailed, which serves as a starting point to study their anti-COVID-19 potential. SARS-CoV-2 targets (its proteins) are defined. Findings from in silico, in vitro and in vivo studies of a wide variety of phenolic compounds are shown, emphasizing their mechanism of action, which is fundamental for drug design. Furthermore, clinical trials have demonstrated the effectiveness of PCs in the prevention and as a possible therapeutic management against COVID-19.enghttps://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by/4.0PolyphenolsSARS-CoV-2COVID-19CoronavirusMedicine naturalImmune systemhttps://purl.org/coar/resource_type/c_dcae04bc